Experiment: 2KXE

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
2	2D 1H-1H TOCSY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
3	2D DQF-COSY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
4	3D HNCACB	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
5	3D CBCA(CO)NH	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
6	3D HNCA	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
7	3D HN(CO)CA	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
8	3D HCCH-COSY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
9	3D HCCH-TOCSY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
10	3D 1H-15N NOESY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
11	3D 1H-15N TOCSY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
12	3D 1H-13C NOESY	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
13	3D HMQC-NOESY-HMQC	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
14	2D 1H-15N HSQC	0.7-3.3mM sodium phosphate; 0.7-3.3mM [U-99% 15N] sodium phosphate; 0.7-3.3mM [U-99% 13C; U-99% 15N] sodium phosphate; 95% H2O/5% D2O	95% H2O/5% D2O	0.15	5.5	ambient	318
15	2D 1H-15N HSQC	3.3mM [U-99% 15N] sodium phosphate; 100% D2O	100% D2O	0.15	5.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	750
2	Bruker	DMX	500

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	50
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CNS	1.1
2	refinement	CNS	1.1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.